(Total Views: 300)
Posted On: 02/03/2021 10:00:47 AM
Post# of 333
$RGBP REGEN BIOPHARMA INC. Regen BioPharma, Inc. Receives FDA Clearance to Initiate Clinical Trial of HemaXellerate. Company to initiate Phase I Clinical Trial for IMmune Modulatory Personalized Cell Therapy
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Cara Thera Low Float Stocks
https://i.makeagif.com/media/12-01-2018/6WgD08.mp4
https://i.makeagif.com/media/12-01-2018/6WgD08.mp4